Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Alagebrium (ALT-711) in Chronic Heart Failure
2007-000319-27Phase 2Active
- Sponsor
- Alteon
- Start
- Apr 2007
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 2, randomised, double-blind trial in chronic heart failure (CHF) comparing Alagebrium chloride with Placebo (2 arms). Primary endpoint: Aerobic capacity (VO2max) at exercise testing. Started Apr 2007; status: active.
02
Drugs
alagebrium
03
Conditions
chronic heart failure (CHF)
Beyond the preview
Go deeper on 2007-000319-27.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on 2007-000319-27.